SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Clinical outcomes from blended care therapy for anxiety and depression in the year after treatment
16 references·0 citing·47 second hop
Clinical outcomes from blended care therapy for anxiety and depression in the year after treatment (2024)Clinical outcomes from blended care thera…Screening for Depression and Suicide Risk in Adults (2023)Screening for Depression and …Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 (2022)Global, regional, and nationa…The effects of psychotherapies for depression on response, remission, reliable change, and deterioration: A meta‐analysis (2021)The effects of psychotherapie…Sensitivity to change and minimal clinically important difference of the 7-item Generalized Anxiety Disorder Questionnaire (GAD-7) (2020)Sensitivity to change and min…Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols (2018)Guidelines for Inclusion of P…Do guided internet-based interventions result in clinically relevant changes for patients with depression? An individual participant data meta-analysis (2018)Do guided internet-based inte…Internet-delivered transdiagnostic and tailored cognitive behavioral therapy for anxiety and depression: a systematic review and meta-analysis of randomized controlled trials (2016)Internet-delivered transdiagn…Screening for anxiety disorders with the GAD-7 and GAD-2: a systematic review and diagnostic metaanalysis (2015)Screening for anxiety disorde…Response rates for CBT for anxiety disorders: Need for standardized criteria (2015)Response rates for CBT for an…Barriers to mental health treatment: results from the WHO World Mental Health surveys (2013)Barriers to mental health tre…Two-year course of depressive and anxiety disorders: Results from the Netherlands Study of Depression and Anxiety (NESDA) (2011)Two-year course of depressive…Validity of the GAD-7 scale as an outcome measure of disability in patients with generalized anxiety disorders in primary care (2010)Validity of the GAD-7 scale a…Unified Protocol for Transdiagnostic Treatment of Emotional Disorders: Therapist Guide (2010)Unified Protocol for Transdia…Anxiety Disorders in Primary Care: Prevalence, Impairment, Comorbidity, and Detection (2007)Anxiety Disorders in Primary …A Brief Measure for Assessing Generalized Anxiety Disorder (2006)A Brief Measure for Assessing…The PHQ-9 (2001)The PHQ-9Clinical significance: A statistical approach to defining meaningful change in psychotherapy research. (1991)Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication (2005)CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials (2010)Randomized clinical trial of cognitive behavioral therapy (CBT) versus acceptance and commitment therapy (ACT) for mixed anxiety disorders. (2012)Positive affect treatment for depression and anxiety: A randomized clinical trial for a core feature of anhedonia. (2019)Anxiety Disorders (2022)An Inventory for Measuring Depression (1961)The Patient Health Questionnaire-2 (2003)Validation and Standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the General Population (2008)An Ultra-Brief Screening Scale for Anxiety and Depression: The PHQ-4 (2009)The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: a systematic review (2010)An inventory for measuring clinical anxiety: Psychometric properties. (1988)The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. (1992)The Global Assessment Scale (1976)The World Mental Health (WMH) Survey Initiative version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI) (2004)No health without mental health (2007)Undertreatment of people with major depressive disorder in 21 countries (2016)Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 (2017)Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (2018)A New Depression Scale Designed to be Sensitive to Change (1979)The Structured Clinical Interview for DSM-III-R (SCID) (1992)The PHQ-9: A New Depression Diagnostic and Severity Measure (2002)Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement (2009)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (2009)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. (2009)Anxiety disorders (2017)Depression and Anxiety in Hong Kong during COVID-19 (2020)Anxiety disorders (2021)Principles of Good Practice for the Translation and Cultural Adaptation Process for Patient-Reported Outcomes (PRO) Measures: Report of the ISPOR Task Force for Translation and Cultural Adaptation (2005)SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials (2013)SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials (2013)Incorporating the patient experience into regulatory decision making in the USA, Europe, and Canada (2018)Maximising the impact of patient reported outcome assessment for patients and society (2019)Great Expectations: recommendations for improving the methodological rigor of psychedelic clinical trials (2022)Diagnostic and Statistical Manual of Mental Disorders(DSM) (2008)How the COVID‐19 pandemic has changed our lives: A study of psychological correlates across 59 countries (2020)Validation of the Fear of COVID-19 Scale in a US College Sample (2020)Psychometric Properties of the Generalized Anxiety Disorder Scale-7 Item (GAD-7) in a Large Sample of Chinese Adolescents (2021)Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010 (2013)The Lancet Commission on global mental health and sustainable development (2018)Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic (2021)Quantifying the global burden of mental disorders and their economic value (2022)The social determinants of mental health and disorder: evidence, prevention and recommendations (2024)Worldwide Prevalence and Disability From Mental Disorders Across Childhood and Adolescence (2024)An invariant dimensional liability model of gender differences in mental disorder prevalence: Evidence from a national sample. (2011)Unified Protocol for Transdiagnostic Treatment of Emotional Disorders: A Randomized Controlled Trial (2012)The Unified Protocol for Transdiagnostic Treatment of Emotional Disorders Compared With Diagnosis-Specific Protocols for Anxiety Disorders (2017)
this work references cited by second hop

References

  • 2001The PHQ-944,795 cited
  • 2006A Brief Measure for Assessing Generalized Anxiety Disorder31,695 cited
  • 2022Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 20196,444 cited
  • 2007Anxiety Disorders in Primary Care: Prevalence, Impairment, Comorbidity, and Detection4,728 cited
  • 2015Screening for anxiety disorders with the GAD-7 and GAD-2: a systematic review and diagnostic metaanalysis1,876 cited
  • 2013Barriers to mental health treatment: results from the WHO World Mental Health surveys1,285 cited
  • 2010Unified Protocol for Transdiagnostic Treatment of Emotional Disorders: Therapist Guide874 cited
  • 2018Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols813 cited
  • 2020Sensitivity to change and minimal clinically important difference of the 7-item Generalized Anxiety Disorder Questionnaire (GAD-7)639 cited
  • 2015Response rates for CBT for anxiety disorders: Need for standardized criteria592 cited
  • 2021The effects of psychotherapies for depression on response, remission, reliable change, and deterioration: A meta‐analysis362 cited
  • 2011Two-year course of depressive and anxiety disorders: Results from the Netherlands Study of Depression and Anxiety (NESDA)354 cited
  • 2016Internet-delivered transdiagnostic and tailored cognitive behavioral therapy for anxiety and depression: a systematic review and meta-analysis of randomized controlled trials

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

335 cited
  • 2018Do guided internet-based interventions result in clinically relevant changes for patients with depression? An individual participant data meta-analysis303 cited
  • 2010Validity of the GAD-7 scale as an outcome measure of disability in patients with generalized anxiety disorders in primary care298 cited
  • 2023Screening for Depression and Suicide Risk in Adults283 cited
  • Cited by

    No citing works inside the corpus for this window.